D. Chevalier

发表

Identification of a novel splice-site mutation in the CYP1A2 gene.

C. Eap, J. Lo-Guidice, C. Cauffiez, 2003, British journal of clinical pharmacology.

First report of a genetic polymorphism of the cytochrome P450 3A43 (CYP3A43) gene: Identification of a loss‐of‐function variant

J. Lafitte, J. Lo-Guidice, C. Cauffiez, 2004, Human mutation.

Functional analysis of CYP2D6.31 variant: Homology modeling suggests possible disruption of redox partner interaction by Arg440His substitution

G. Tucker, F. Blaney, J. Lo-Guidice, 2005, Proteins.

Genetic polymorphism of CYP2U1, a cytochrome P450 involved in fatty acids hydroxylation.

C. L. Lino Cardenas, J. Lo-Guidice, C. Cauffiez, 2010, Prostaglandins, leukotrienes, and essential fatty acids.

Ethnic differences in the distribution of CYP3A5 gene polymorphisms

J. Lo-Guidice, B. Lacarelle, M. Lhermitte, 2006, Xenobiotica; the fate of foreign compounds in biological systems.

Five novel natural allelic variants—951A>C, 1042G>A (D348N), 1156A>T (I386F), 1217G>A (C406Y) and 1291C>T (C431Y)—of the human CYP1A2 gene in a French Caucasian population

J. Lafitte, J. Lo-Guidice, C. Cauffiez, 2001, Human mutation.

Functional characterization of genetic polymorphisms identified in the human cytochrome P450 4F12 (CYP4F12) promoter region.

N. Pottier, J. Lo-Guidice, C. Cauffiez, 2004, Biochemical pharmacology.

Arachidonic acid ω-hydroxylase CYP4A11: inter-ethnic variations in the 8590T>C loss-of-function variant

C. L. Lino Cardenas, F. Migot-Nabias, A. Touré, 2012, Molecular Biology Reports.

Genotoxicity of tungsten carbide-cobalt (WC-Co) nanoparticles in vitro: mechanisms-of-action studies.

E. Lorge, H. Vezin, H. Moche, 2015, Mutation research. Genetic toxicology and environmental mutagenesis.

Identification of genetic variants in the human thromboxane synthase gene (CYP5A1).

J. Lo-Guidice, C. Libersa, M. Lhermitte, 2001, Mutation research.

Genotypic and phenotypic analysis of the polymorphic thiopurine S‐methyltransferase gene (TPMT) in a European population

J. Lafitte, D. Turck, C. Libersa, 1998, British journal of pharmacology.

Sequence analysis, frequency and ethnic distribution of VNTR polymorphism in the 5'-untranslated region of the human prostacyclin synthase gene (CYP8A1).

J. Lo-Guidice, C. Cauffiez, M. Lhermitte, 2002, Prostaglandins & other lipid mediators.

Evidence for a functional genetic polymorphism of the human mercaptopyruvate sulfurtransferase (MPST), a cyanide detoxification enzyme.

J. Lo-Guidice, C. Cauffiez, F. Broly, 2006, Toxicology letters.

Evidence for a functional genetic polymorphism of the human thiosulfate sulfurtransferase (Rhodanese), a cyanide and H2S detoxification enzyme.

J. Lo-Guidice, C. Cauffiez, F. Broly, 2006, Toxicology.

In vitro characterization of four novel non-functional variants of the thiopurine S-methyltransferase.

C. Spire, J. Lo-Guidice, C. Cauffiez, 2003, Biochemical and biophysical research communications.

Molecular analysis of the CYP2F1 gene: identification of a frequent non-functional allelic variant.

J. Lafitte, J. Lo-Guidice, C. Cauffiez, 2007, Mutation research.

Genetic polymorphism of the human cytochrome CYP2A13 in a French population: implication in lung cancer susceptibility.

J. Lafitte, J. Lo-Guidice, C. Cauffiez, 2004, Biochemical and biophysical research communications.

Genetic polymorphism of the human cytochrome P450 CYP4B1: evidence for a non-functional allelic variant.

J. Lafitte, J. Lo-Guidice, C. Cauffiez, 2002, Pharmacogenetics.

Characterisation of novel defective thiopurine S-methyltransferase allelic variants.

M. Loriot, P. Chavatte, J. Lo-Guidice, 2008, Biochemical pharmacology.

Arachidonic acid ω-hydroxylase CYP4A11: inter-ethnic variations in the 8590T>C loss-of-function variant

C. L. Lino Cardenas, F. Migot-Nabias, A. Touré, 2012, Molecular Biology Reports.

Tungsten carbide-cobalt as a nanoparticulate reference positive control in in vitro genotoxicity assays.

Nancy Claude, Fabrice Nesslany, Elisabeth Lorge, 2014, Toxicological sciences : an official journal of the Society of Toxicology.

Characterization of new mutations in the coding sequence and 5'-untranslated region of the human prostacyclin synthase gene (CYP8A1)

J. Lo-Guidice, C. Cauffiez, C. Libersa, 2001, Human Genetics.

Carboxylated nanodiamonds can be used as negative reference in in vitro nanogenotoxicity studies

E. Lorge, V. Paget, H. Girard, 2017, Journal of applied toxicology : JAT.

Human CYP4F12 genetic polymorphism: identification and functional characterization of seven variant allozymes.

N. Pottier, J. Lo-Guidice, C. Cauffiez, 2004, Biochemical pharmacology.

Molecular analysis of the N-acetyltransferase 1 gene (NAT1*) using polymerase chain reaction-restriction fragment-single strand conformation polymorphism assay.

J. Lo-Guidice, D. Allorge, D. Chevalier, 2000, Pharmacogenetics.

Genetic polymorphisms of Glycine N-acyltransferase (GLYAT) in a French Caucasian population

C. L. Lino Cardenas, J. Lo-Guidice, C. Cauffiez, 2010, Xenobiotica; the fate of foreign compounds in biological systems.

Identification by single-strand conformational polymorphism analysis of known and new mutations of the CYP3A5 gene in a French population.

V. Bourgarel-Rey, J. Lo-Guidice, C. Solas, 2006, Toxicology letters.

CYP2F1 genetic polymorphism: Identification of interethnic variations

J. Lo-Guidice, C. Cauffiez, F. Migot-Nabias, 2007, Xenobiotica; the fate of foreign compounds in biological systems.

CYP2A13 genetic polymorphism in French Caucasian, Gabonese and Tunisian populations

N. Pottier, J. Lo-Guidice, C. Cauffiez, 2005, Xenobiotica; the fate of foreign compounds in biological systems.

Genetic polymorphism of CYP4A11 and CYP4A22 genes and in silico insights from comparative 3D modelling in a French population.

P. Chavatte, C. L. Lino Cardenas, J. Lo-Guidice, 2011, Gene.